STEVENS JOHNSON SYNDROME PADA PASIEN HIV

Authors

  • bevi dewi citra BAGIAN ILMU PENYAKIT DALAM RSUP M.DJAMIL/FAKULTAS KEDOKTERAN UNIVERSITAS ANDALAS
  • Raveinal masri Consultant in Allergy Immunology Subdivision of Internal Medicine, Medical Faculty of Andalas University/M.Djamil Hospital

DOI:

https://doi.org/10.32883/hcj.v5i2.764

Abstract

Stevens Johnson Syndrome (SJS) are form of drugs hypersensitivity reaction with high morbidity besides Toxic Epidermal Necrolysis (TEN). HIV-patients are one of the population with higher risk. Its due to, in this population had multifactorial aspects and related with drug metabolism, dysregulation of the immune systems (immune hyperactivation, patients cytokine profile and CD4 cell count), oxidative stress, genetic predisposition,and viral factors. A case of female, 42 years old, who had been known as HIV patients with clinical stage 3 had Stevens Johnson Syndrome. Allegedly, it caused by antiretroviral drugs (nevirapine), which she consumed for 3 weeks. Patient also has fever and  hepatitis drug induced. For the the treatment, we stopped previous  combination of antiretroviral drugs immediately and replaced by another combination. Furthermore, patient also had corticosteroid therapy and others supportive treatments, such as intra venous fluid, adequate nutrition, antibiotic, antifungal and also had eyelid, oral, nose and skin treatment. Patient showed clinical improvements and and improvement of liver function test after received treatments for one week in hospital  

Keywords: Stevens Johnson Syndrome, HIV, antiretroviral

Author Biographies

bevi dewi citra, BAGIAN ILMU PENYAKIT DALAM RSUP M.DJAMIL/FAKULTAS KEDOKTERAN UNIVERSITAS ANDALAS

internal medicine

Raveinal masri, Consultant in Allergy Immunology Subdivision of Internal Medicine, Medical Faculty of Andalas University/M.Djamil Hospital

Allergy Imunology Subdivision

References

1. Vijaykumar Lakshman Lamani, Basavaraj C Kotinatot, Aruna Bhushan. Nevirapine induced Stevens-Johnson syndrome. International Journal of Current Research and Academic Revie. 2015, Volume 3(2): 156-8
2. Karnen Garna Baratawidjaja, Iris Rengganis. Reaksi Obat Dengan Lepuh dalam Alergi Dasar. Jakarta: Interna Publishing. 2009; 560-79
3. Syed Ahmad Ali Gardezi et al. A clinicoetiological study of Stevens-Johnson syndrome and toxic epidermal necrolysis. Journal of Pakistan Association of Dermatologists. 2013; volume 23(1) :5-13.
4. Allanore LV, Roujeau JC. Epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis). In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leff el DJ, editors. Fittzpatrick’s Dermatology in General Medicine. 7th ed. New York: McGraw-Hill Companies Inc; 2008. pp. 347-54
5. Z Zingela, A Bronkhorst, W M Qwesha, B P Magigaba. Fatal nevirapine-induced Stevens-Johnson syndrome with HIV-associated mania, case report. S Afr J HIV Med Volume 15(2), 2014 :65-66
6. Rannakoe Lehloenya. Management of Stevens Johnson Syndrome and Toxic Epidermal Necrolysis. Current Allergy & Clinical Immunology, August 2007 Vol 20, No. 3; 124-8
7. Fakoya A, Omenyi P, Anthony P et al. Stevens - Johnson Syndrome and Toxic Epidermal Necrolysis; Extensive Review of Reports of Drug-Induced Etiologies, and Possible Therapeutic Modalities. Macedonian Journal of Medical Sciences. 2018 Apr 15; 6(4):730-738.
8. Evy Yunihastuti, Alvina Widhani, Teguh Harjono Karjadi. Asia Pac Allergy 2014;4:54-67
9. White K, Riichiro Abe, Ardern-Jones M et al. SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation. J Allergy Clin Immunol Pract Volume 6, No.1. 2018;39-69
10. Hari Darmawan. Sindrom Stevens-Johnson Diduga Akibat Siprofloksasin, case report. Cermin Dunia Kedokteran, CDK-217 volume 41 (6). 2014. 432-5
11. HHF Ho. Diagnosis and Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. The Hongkong Medical Diary. Volume 13 (10). 2008. 17-20
12. Schneider J, Cohen P. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures. Adv Ther (2017) 34:1235–1244
13. Kementerian kesehatan Republik Indonesia. Pedoman Nasional Tatalaksana klinis infeksi HIV dengan Terapi Antiretroviral Pada Orang Dewasa. Direktorat Jendral Pengendalian Penyakit dan Penyehatan Lingkungan. 2011
14. Kantorinis N, Dieterich D. Hepatotoxicity of Antiretroviral Therapy. AIDS Rev, Volume 5, 2003; 36-43
15. Suharjo Cahyono. Penyakit hati Akibat Obat dalam tatalaksana klinis di Bidang Gastro dan Hepatologi. Jakarta; Sagung Seto. 338-345
16. Marfatia, Smita M. Adverse Drug reactions (ADR due To Anti Retroviral (ARV) : issues and Challenges. Indian J Sex transm Dis, Volume 2005; 26 (1,2). 2005. ; 40-49
17. Zimmermann S, Sekula P, Venhoff M, Motschall E, Knaus J, Schumacher M, et al. Systemic immunomodulating therapies for Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. JAMA Dermatol 2017;153:514-22.

Downloads

Published

2020-05-25

How to Cite

citra, bevi dewi, & masri, R. (2020). STEVENS JOHNSON SYNDROME PADA PASIEN HIV. Human Care Journal, 5(2), 545–553. https://doi.org/10.32883/hcj.v5i2.764

Issue

Vol. 5 No. 2 (2020): Human Care Journal Special Edition

Section

Articles

License

Setiap naskah yang terbit di jurnal Human Care ini adalah dianggap sebagai karya dari penulis.

Pemegang hak cipta adalah jurnal Human Care. Semua pembaca memiliki akses untuk masuk ke jurnal Human Care dan menjadikan naskah yang terbit di jurnal Human Care sebagai referensi.